Delivery Order SPE2DB22D2206-SPE2DB24FFJ17

Award Date 1/30/24
Potential Completion Date 1/31/24
Potential Value $4.9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide LYRICA 75 mg capsules in 90 count packages. The contract has a potential value of $3,242.38 and a completion date of February 14, 2024. Amerisourcebergen Drug Corp is the prime contractor and the place of performance is Conshohocken, Pennsylvania. This delivery order is issued under a larger...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $7,770.84 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide LYRICA 75 MG CAPSULE 90S. This delivery order is part of an indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver pharmaceutical products and medical supplies in support of Department of Defense military treatment...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $2,187.24 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide LYRICA 100 MG CAPSULE 90S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide LYRICA 25 MG CAPSULE 90S. The contract has a potential value of $2,250.50 and a completion date of March 6, 2024. This delivery order is likely part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA to...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $4,327.82 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide LYRICA 75 MG CAPSULE 90S. This delivery order falls under an existing indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,206.64 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide LYRICA 75 MG CAPSULE 90S. The contract has a completion date of March 6, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 to deliver...
Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical to supply LYRICA 75 MG CAPSULE 90S pharmaceutical products. The $3,654.63 order was awarded on November 20, 2023 and requires completion by November 21, 2023. Performance will take place at Amerisourcebergen's headquarters location in Conshohocken, Pennsylvania. No set-aside designation was applied to this order....
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order worth $4,848.21 by the Defense Logistics Agency (DLA) to provide Lyrica 75 mg capsules with a completion date of March 1, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, which has a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as...
Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical to supply 4563095117 LYRICA 75 MG CAPSULE 90S. The $3,192.48 order was awarded on December 13, 2023 for product delivery by December 14, 2023 to the DLA facility located in Conshohocken, Pennsylvania. As a prime contractor and leading pharmaceutical distributor, Amerisourcebergen routinely provides brand name and...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of LYRICA 75 MG CAPSULE 90S. The award, valued at $17,770.55, has a completion date of February 27, 2024. Amerisourcebergen Drug Corp, a for-profit organization, provides a wide range of pharmaceutical products and medical supplies to government agencies, particularly the Department of Defense. This delivery order is...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FFJ17
    Delivery Order

Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, was awarded a firm fixed price delivery order contract from the Defense Logistics Agency (DLA) to provide LYRICA 75 MG CAPSULE 90S. The contract has a potential value of $4,888.63 and a completion date of January 31, 2024. This award is part of a larger indefinite delivery contract (IDC) worth up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and medical facilities worldwide. The contract does not have a set-aside designation.

Generated 4/30/24, 5:39 PM